Juan Antonio García Velasco_IVIRMA Madrid_c

Juan García Velasco, M.D., Ph.D.

Director of IVI Madrid

IVI Madrid

Contact info:

Biography

Juan García-Velasco, MD, PhD, is Director of IVI Madrid, where he attends his patients. He is also Professor of Obstetrics and Gynaecology at Rey Juan Carlos University, Madrid, Spain, where he is Director of their Master’s Degree Programme in Human Reproduction.

Professor García-Velasco graduated from University Medical School, Madrid, in 1990 and received his obstetrics and gynaecology certification from La Paz Hospital, Madrid, in 1995. He completed his PhD in Medicine at Autonoma University, Madrid, in 1995, and from 1997 to 1998 studied at Yale University, New Haven, CT, under a Reproductive Endocrinology and Infertility Fellowship.

Professor García-Velasco’s main research interests have been in IVF and endometriosis. He is the Principal Investigator of projects funded by the Ministry of Education and Ministry of Health in Spain, and has received awards from the Spanish Fertility Society, Spanish Society of Obstetrics and Gynaecology, and the European Society of Human Reproduction and Embryology. He has published over 190 peer-reviewed articles and 22 book chapters on human reproduction, endometriosis and hypo- and hyper-ovarian stimulation response. He is the Co-Editor of Reproductive Biomedicine Online.

	Complutense University Medical School, Madrid Spain 1990
Ob/Gyn Board Certified	La Paz Hospital 1992-1995
PhD degree in Medicine	Autonoma University Madrid Spain, 1995
Fellowship in Reproductive Endocrinology & Infertility	Yale University, USA 1997/98
Full Professor of Obstetrics and Gynecology	Rey Juan Carlos University, Madrid, Spain
Director of the Master in Human Reproduction	Rey Juan Carlos University and IVI

Honors and recognition

Spanish Fertility Society	(1999 y 2009)
Spanish Ob/Gyn Society	(1997)
ESHRE	(2011)

Research activity:

191 peer reviewed articles, 22 book chapters and 4 edited books.

Publications

ICSI does not offer any benefit over conventional IVF across different ovarian response categories in non-male factor infertility: a European multicenter analysis.
Drakopoulos P García-Velasco JA Bosch E Blockeel C De Vos M Santos-Ribeiro S Makrigiannakis A Tournaye H Polyzos NP
J Assist Reprod Genet. 2019 Aug 22. doi: 10.1007/s10815-019-01563-1. [Epub ahead of print]

Corifollitropin alfa for ovarian stimulation in in vitro fertilization: a systematic review and meta-analysis of randomized controlled trials.
Cozzolino M Vitagliano A Cecchino GN Ambrosini G Garcia-Velasco JA
Fertil Steril. 2019 Apr;111(4):722-733. doi: 10.1016/j.fertnstert.2018.11.047.

Serum and follicular fluid Stem Cell Factor assay in IVF poor responder and normal responder patients: a predictive biomarker of oocyte retrieval.
Cozzolino M Cruz M Patel A Patel J Pacheco A Garcia-Velasco JA
Arch Gynecol Obstet. 2019 May 6. doi: 10.1007/s00404-019-05172-2. [Epub ahead of print]

Mitochondrial DNA copy number as a predictor of embryo viability.
Cecchino GN Garcia-Velasco JA
Fertil Steril. 2019 Feb;111(2):205-211. doi: 10.1016/j.fertnstert.2018.11.021. Epub 2019 Jan 2. Review.

Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A García-Velasco JA Domingo J Pellicer A Remohí J
Hum Reprod, 33(12):2222-2231, 2018.

Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients.
Mol BW Bossuyt PM Sunkara SK García-Velasco JA Venetis C Sakkas D Lundin K Simón C Taylor HS Wan R Longobardi S Cottell E D'Hooghe T
Fertil Steril, 109(6):968-979, 2018.

Pancreatic autoimmunity: An unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure.
Alecsandru D Barrio A Andia V Cruz E Aparicio P Serna J Cruz M Pellicer A García-Velasco JA
PLoS One, 13(10):NA-NA, 2018.

Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A García-Velasco JA Domingo J Pellicer A Remohí J
Hum Reprod, 33(12):2222-2231, 2018.

How time to healthy singleton delivery could affect decision-making during infertility treatment: a Delphi consensus.
Bosch E Bulletti C Copperman AB Fanchin R Yarali H Petta CA Polyzos NP Shapiro D Ubaldi FM García-Velasco JA Longobardi S D'Hooghe T Humaidan P Delphi TTP Consensus Group
Reprod Biomed Online, NA:NA -NA, 2018.

Mathematical model to study the aging of the human follicle according to the telomerase activity.
Portillo AM Varela E García-Velasco JA
J Theor Biol, 462:446-454, 2018.

Hysteroscopic septum resection and reproductive medicine: A SWOT analysis.
Spanish Infertility SWOT Group (SISG) Checa MA Bellver J Bosch E Espinós JJ Fabregues F Fontes J García-Velasco JA Requena A
Reprod Biomed Online, 37(6):709-715, 2018.

Ovarian endometriosis and infertility: in vitro fertilization (IVF) or surgery as the first approach?
Lessey BA Gordts S Donnez O Somigliana E Chapron C García-Velasco JA Donnez J
Fertil Steril, 110(7):1218-1226, 2018.

Cumulative live birth rates according to the number of oocytes retrieved following the first ovarian stimulation for IVF/ICSI: A multicentre multinational analysis including ~15.000 women.
Polyzos NP Drakopoulos P Parra J Pellicer A Santos-Ribeiro S Tournaye H Bosch E García-Velasco JA
Fertil Steril, 110(4):661-670, 2018.

The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation
Drakopoulos P Santos-Ribeiro S Bosch E García-Velasco JA Blockeel C Romito A Tournaye H Polyzos NP
Front Endocrinol (Lausanne), 9:361-361, 2018.

Endometrioma, fertility, and assisted reproductive treatments: connecting the dots.
Cecchino GN García-Velasco JA
Curr Opin Obstet Gynecol, 30(4):223-228, 2018.

Ovarian manipulation in ART: going beyond physiological standards to provide best clinical outcomes.
Ortega I García-Velasco JA Pellicer A
J Assist Reprod Genet, 35(10):1751-1762, 2018.

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study.
Barrenetxea G García-Velasco JA Aragón B Osset J Brosa M López-Martínez N Coroleu B
Reprod Biomed Soc Online, 5:46-59, 2018.

Fertility, IVF and reproductive genetics.
Varela E Sánchez-de-Puerta I García-Velasco JA
Curr Opin Obstet Gynecol, 30(3):203-208, 2018.

Corrigendum: Letter to the Editor: Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates.
La Marca A Blockeel Bosch E Fanchin R Fatemi HM Fauser BC García-Velasco JA Humaidan P Tarlatzis BC Nelson SM
Hum Reprod, 33(7):1372-1372, 2018.

How new technical knowledge impacts clinical approach to infertile patients.
García-Velasco JA Seli E
Curr Opin Obstet Gynecol, 30(3):137-138, 2018.

Very low anti-müllerian hormone concentrations are not an independent predictor of embryo quality and pregnancy rate.
Pacheco A Cruz M Iglesias C García-Velasco JA
Reprod Biomed Online, 37(1):113-119, 2018.

Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates.
La Marca A Blockeel C Bosch E Fanchin R Fatemi HM Fauser BC García-Velasco JA Humaidan P Tarlatzis BC Nelson SM
Hum Reprod, 33(5):982-983, 2018.

The role of mitochondrial activity in Female fertility and assisted reproductive technologies: overview and current insights.
Cecchino GN Seli E Alves da Motta EL García-Velasco JA
Reprod Biomed Online, 36(6):686-697, 2018.

Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
Diaz-Garcia C Domingo J García-Velasco JA Herraiz S Mirabet V Iniesta I Cobo A Remohí J Pellicer A
Fertil Steril, 109(3):478-485, 2018.

Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors.
Fabris AM Cruz M Iglesias C Pacheco A Patel A Patel J Fatemi HM García-Velasco JA
Reprod Biomed Online. 2017 May 19. pii: S1472-6483(17)30235-3. doi: 10.1016/j.rbmo.2017.05.009.

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A, Nelson SM Fauser BC García-Velasco JA Klein BM Arce JC ESTHER-1 study group.
Fertil Steril, 107 (2): 387-396.e4, 2017.

Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates.
Cerrillo M Herrero L Guillen A Mayoral M García-Velasco JA
Rambam Maimonides Med J. 2017 Apr 28;8(2). doi: 10.5041/RMMJ.10297.

Sperm DNA fragmentation: from promising to estandarization
Pacheco A García-Velasco JA
Transl Androl Urol. 6 (Suppl 4):S341-S342, 2017

Type of gonadotropin used during controlled ovarian stimulation induces differential gene expression in human cumulus cells: A randomized study.
Cruz M Requena A Agudo Garcillán D García-Velasco JA
Eur J Obstet Gynecol Reprod Biol. 2017 Jun 8;215:124-133. doi: 10.1016/j.ejogrb.2017.06.014. [Epub ahead of print]

Type of gonadotropin used during controlled ovarian stimulation induces differential gene expression in human cumulus cells: A randomized study.
Cruz M Requena A Agudo Garcillán D García-Velasco JA
Eur J Obstet Gynecol Reprod Biol. 2017 Jun 8;215:124-133. doi: 10.1016/j.ejogrb.2017.06.014. [Epub ahead of print]

Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen.
Alecsandru D García-Velasco JA
Fertil Steril. 2017 Jun;107(6):1273-1278. doi: 10.1016/j.fertnstert.2017.04.018. Epub 2017 May 10. Review.

Polycystic ovary syndrome throughout a woman's life.
Bellver J Rodríguez-Tabernero L Robles A Muñoz E Martínez F Landeras J García-Velasco JA Fontes J Alvarez M Álvarez C Acevedo B
J Assist Reprod Genet. 2017 Sep 27. doi: 10.1007/s10815-017-1047-7. [Epub ahead of print] Review.

Review the 'peer review'.
Blockeel C Drakopoulos P Polyzos NP Tournaye H García-Velasco JA
Reprod Biomed Online. 2017 Aug 24. pii: S1472-6483(17)30379-6. doi: 10.1016/j.rbmo.2017.08.017. [Epub ahead of print]

Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates.
Cerrillo M Herrero L Guillen A Mayoral M García-Velasco JA
Rambam Maimonides Med J. 2017 Apr 28;8(2). doi: 10.5041/RMMJ.10297.

Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors.
Fabris AM Cruz M Iglesias C Pacheco A Patel A Patel J Fatemi HM García-Velasco JA
Reprod Biomed Online. 2017 May 19. pii: S1472-6483(17)30235-3. doi: 10.1016/j.rbmo.2017.05.009. [Epub ahead of print]

Introduction: Immunology and assisted reproductive technology in the 21st century.
García-Velasco JA
Fertil Steril. 2017 Jun;107(6):1267-1268. doi: 10.1016/j.fertnstert.2017.04.017. Epub 2017 May 5.

Impact of very low anti-Müllerian hormone on pregnancy success.
Pacheco A Cruz M García-Velasco JA
Curr Opin Obstet Gynecol. 2017 Feb 15. doi: 10.1097/GCO.0000000000000354. [Epub ahead of print]

Sperm DNA integrity: from 'promising' to standardization.
Pacheco A García-Velasco JA
Transl Androl Urol. 2017 Sep;6(Suppl 4):S341-S342. doi: 10.21037/tau.2017.08.10. No abstract available.

Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen.
Alecsandru D García-Velasco JA
Fertil Steril. 2017 Jun;107(6):1273-1278. doi: 10.1016/j.fertnstert.2017.04.018. Epub 2017 May 10. Review.

Telomeres in aging and reproduction.
Varela E Sánchez de Puerta I García-Velasco JA
Current Opinion in Obstetrics and Gynecology (in preparation).

IVF: progress through Technology development .
García-Velasco JA Seli E
Curr Opin Obstet Gynecol, 28:149-50, 2016.

Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease.
Puente J Fabris A Patel J Patel A Cerrillo M Requena A García-Velasco JA
Reprod Biol Endocrinol 2016; 14: 60

Assisted reproductive techniques after fertility-sparing treatments in gynecological cancers.
Zapardiel I Cruz M Diestro MD Requena M García-Velasco JA
Hum Reprod Update 2016;22(3)

Type of gonadotropin during controlled ovarian stimulation affects the endocrine profile in follicular fluid and apoptosis rate in cumulus cells.
Requena A Cruz M Agudo Garcillán D Pacheco A García-Velasco JA
Eur J Obstet Gynecol Reprod Biol. 2016; 197:142-146

Using donor gametes, embryos.
Iglesias C Ortega I García-Velasco JA

High responder: optimizing your stimulation without complications.
Martínez Salazar J Ortega I García-Velasco JA

Dual Triggering with Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients with a high Immature Oocyte Rate.
Fabris A Cruz M Legidos V Iglesias C Muñoz M García-Velasco JA
Reproductive Sciences (SAGE), 1-5, 2016.

Strategies to manage refractory endometrium: state of the art in 2016.
García-Velasco JA Acevedo B Alvarez C Alvarez M Bellver J Fontes J Landeras J Manau D Martínez F Muñoz E Robles A Rodríguez-Tabernero L
Reproductive BioMedicine Online. 32:474-489, 2016.

Ovarian Stimulation in Cancer Patients.
Muñoz E González N Aguilar J Muñoz L García-Velasco JA
Fertility Preservation Basic Principles.50-55, 2016.

Excessive Age-Related Decline in Functional Ovarian Reserve in Infertile Women: Prospective Cohort of 15,500 Women.
Iliodromiti S Iglesias C Messow CM Cruz M García-Velasco JA Nelson SM
J Clin Endocrinol Metab, 101(9):3548-54, 2016.

Oocyte cryopreservation for Fertility Preservation in women with cancer.
Domingo J García-Velasco JA
Curr Opin Endocrinol Diabetes Obes, 23: 465-469, 2016.

Oocytes vitrification as an efficient option for elective fertility preservation (EFP).
Cobo A García-Velasco JA Coello A Domingo J Pellicer A Remohí J
Fertil Steril, 105:755-764, 2016.

Exccesive age-related decline in functional ovarian reserve in infertile women: prospective cohort of 15500 women.
Iliodromiti S Iglesias C Messow CM Cruz M García-Velasco JA Nelson SM
J Clin Endocrinol Metab, 10:3548-3554, 2016

Ethnicity is an independent predictor of IVF-ICSI outcome: a study of 5549 cycles in Spain and India.
Patel A Patel J Cruz M Gupte-Shah A García-Velasco JA Banker MR
Gynecol Endocrinol, 32:819-822, 2016.

Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers
Zapardiel I Cruz M Diestro MD Requena A García-Velasco JA
Hum Reprod Update, 22, 2016.

Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease
Puente J Fabris A Patel J Patel A Cerrillo M Requena A García-Velasco JA
Reprod Biol Endocrinol, 14(1):60, 2016

Response: in reference to 'Strategies to manage refractory endometrium: state of the art 2016'.
García-Velasco JA Acevedo B Alvarez C Alvarez M Bellver J Fontes J Landeras J Manau D Martínez F Muñoz E Robles A Rodriguez-Tabernero L
Reprod Biomed Online, 33:605, 2016

The state of "freeze-for-all" in human ARTs.
Basile N García-Velasco JA
J Assist Reprod Genet, 33(12):1543-1550, 2016

Ovarian Stimulation in Cancer Patients. Fertility Preservation Basic Principles.
Muñoz E González N Aguilar J Muñoz L García-Velasco JA Nalini M Pankaj T Puneet R
Fertility Preservation Society (India). 2016

Type of gonadotropin during controlled ovarian stimulation affects the endocrine profile in follicular fluid and apoptosis rate in cumulus cells
Requena A Cruz M Agudo Garcillán D Pacheco A García-Velasco JA
Eur J Obstet Gynecol Reprod Biol, 197:142-6, 2016.

A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility.
Gizzo S García-Velasco JA Heiman F Ripellino C Bühler K
Int J Womens Health. 8:683-689, 2016.

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A Nelson SM Fauser BC García-Velasco JA Klein BM Arce JC
ESTHER-1 study group. Fertil Steril. 107:387-396, 2017.

Ethnicity is an independent predictor of IVF-ICSI outcome: a study of 5,549 cycles in Spain and India.
Patel AP Patel JA Cruz M Gupte-Shah A García-Velasco JA Banker MR
Gynecol Endocrinol. 32:819-822, 2016.

Preimplantation genetic screening - what a wonderful world it would be!
García-Velasco JA Fauser BC
Reprod Biomed Online. 32:337-8. 2016.

Why all women should freeze their eggs.
Cobo A García-Velasco JA
Curr Opin Obstet Gynecol. 28:206-10, 2016.

Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers.
Zapardiel I Cruz M Diestro MD Requena A García-Velasco JA
Hum Reprod Update. 2016.

Oocyte vitrification as an efficient option for elective fertility preservation.
Cobo A García-Velasco JA Coello A Domingo J Pellicer A Remohí J
Fertil Steril. 105:755-764, 2016.

Meet our new editor
García-Velasco JA
Reprod Biomed Online. 31:717, 2015.

To pill or not to pill in GnRH antagonist cycles: that is the question!
García-Velasco JA Fatemi HM
Reprod Biomed Online, 30:39-42, 2015.

To pill or not to pill in GnRH-antagonist cycles: still an open debate.
García-Velasco JA Fatemi HM
Reprod Biomed Online, 31:445, 2015.

IVF: a short but exciting story.
García-Velasco JA Seli E
Curr Opin Obstet Gynecol, 27:165-6, 2015.

Ongoing pregnancy rates in intrauterine insemination are affected by late follicular-phase progesterone levels.
Requena A Cruz M Pacheco A García-Velasco JA
Fertil Steril 2015; 104:879-883.

Progesterone supplementation in the frozen embryo transfer cycle.
Ortega I García-Velasco JA
Curr Opin Obstet Gynecol. 2015

Large bilateral endometrioma in IVF.
García-Velasco JA Ortega I
2015

ART & PCOS.
Ortega I García-Velasco JA
2015

Ovarian stimulation in patients with breast cancer.
Muñoz E González N Muñoz L Aguilar J García-Velasco JA
Ecancermedicalscience. Creative Commons Attribution License. 1-9, 2015.

Oocyte donation outcome after oncological treatment in cancer survivors.
Muñoz E Fernández I Martínez M Tocino A Portela S Pellicer A García-Velasco JA Garrido N
Fertil Steril,103:205-213, 2015.

Vitamin D and in vitro fertilization outcome.
García-Velasco JA Iglesias C Fabris A
Am J Obstet Gynecol, 212(3):412-3, 2015.

Follicular and endocrine dose responses according to anti-Mullerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049).
Bosch E Nyboe Andersen A García-Velasco JA Sutter P Fernández-Sánchez M Visnova H Klein BM Mannaerts B Arce JC
Clin Endocrinol, 83 (6): 902-912, 2015

Ongoing pregnancy rates in intrauterine insemination are affected by late follicular-phase progesterone levels
Requena A Cruz M Pacheco A García-Velasco JA
Fertil Steril, 104:879-883, 2015.

Is there a relationship between time-lapse parameters and embryo sex?
Bronet F Nogales MC Martínez E Ariza M Rubio C García-Velasco JA Meseguer M
Fertil Steril 103:396-401, 2015.

Successful ICSI in an azoospermic and kidney transplant man with type 1 primary hyperoxaluria and first histopathological testicular findings described in the literature.
Balmori C Guillén A Montans J Bronet F García-Velasco JA
Andrologia, 47:109-11, 2015.

The necessity to define the sub-optimal responders.
García-Velasco JA Bosch E
Hum Reprod, 30(12):29-58, 2015.

The use of morphokinetics as a predictor of implantation: a multicentric study to define and validate an algorithm for embryo selection.
Basile N Vime P Florensa M Aparicio-Ruiz B García-Velasco JA Remohí J Meseguer M
Hum Reprod, 30(2):276-83, 2015.

Immune testing and treatment: still an open debate.
Alecsandru D García-Velasco JA
Hum Reprod, 2015

Immunology and human reproduction.
Alecsandru D García-Velasco JA
Curr Opin Obstet Gynecol, 27(3):231-4, 2015

Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases.
Gurbuz AS Deveer R Ozcimen N Ozcimen EE Lawrenz B Banker M García-Velasco JA Fatemi HM
Gynecol Endocrinol. 32:18-20, 2015.

Comprehensive chromosome screening improves embryo selection: a meta-analysis.
Dahdouh EM Balayla J García-Velasco JA
Fertil Steril. 104:1503-12, 2015.

s endometrial receptivity transcriptomics affected in women with endometriosis? A pilot study.
García-Velasco JA Fassbender A Ruiz Alonso M Blesa D D'Hooghe T Simón C
Reprod Biomed Online. 31:647-54, 2015.

Treatment of infertility associated with deep endometriosis: definition of therapeutic balances.
Somigliana E García-Velasco JA
Fertil Steril. 104:764-770, 2015.

Follicular and endocrine dose responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049).
Bosch E Nyboe Andersen A Barri P García-Velasco JA de Sutter P Fernández-Sánchez M Visnova H Klein BM Mannaerts B Arce JC
Clin Endocrinol (Oxf). 83:902-12, 2015.

The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors.
Kol S Humaidan P Alsbjerg B Engmann L Benadiva C García-Velasco JA Fatemi HM Andersen C
Reprod Biomed Online. 30:563-5, 2015

Preimplantation genetic screening using comprehensive chromosome screening: evidence and remaining challenges.
Dahdouh EM Balayla J García-Velasco JA
Hum Reprod. 30:1515-6, 2015.

Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic.
Banker M García-Velasco JA
J Hum Reprod Sci. 8:13-7, 2015.

A multi-centre phase 3 study comparing efficacy and safety of Bemfola(®) versus Gonal-f(®) in women undergoing ovarian stimulation for IVF.
Rettenbacher M Andersen AN García-Velasco JA Sator M Barri P Lindenberg S van der Ven K Khalaf Y Bentin-Ley U Obruca A Tews G Schenk M Strowitzki T Narvekar N Sator K Imthurn B
Reprod Biomed Online. 30:504-13, 2015.

Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.
Fatemi HM García-Velasco JA
Fertil Steril. 103:870-3, 2015.

The use of morphokinetics as a predictor of ?implantation: a multicentric study to define and validate an algorithm for embryo selection.
Basile N Vime P Florensa M Aparicio Ruiz B García-Velasco JA Remohí J Meseguer M
Human Reprod, 30(2);276-83, 2015.

Successful ICSI in an azoospermic and kidney transplant man with type 1 primary hyperoxaluria and first histopathological testicular findings described in the literature
Balmori C Guillén A Montans J Bronet F García-Velasco JA
Andrologia. 47:109-11, 2015.

High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study.
Requena A Cruz M Bosch E Meseguer M García-Velasco JA
Reprod Biol Endocrinol 2014; 26:69

Endocrine profile following stimulation with recombinant follicle-stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin.
Requena A Cruz M Ruiz FJ García-Velasco JA
Reprod Biol Endocrinol 2014; 12:69

Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients.
Fabris A Pacheco A Cruz M Puente J Fatemi HM García-Velasco JA
Fertil Steril, 102(6):1608-12, 2014.

Succesful twin delivery following transmyometrial embryo transfer in a patient with a false uterine cavity.
Muñoz M Galindo N Pérez I-Cano Cruz M García-Velasco JA
Reproductive BioMedicine Online, 28(2): 137-140, 2014

Ehtnicity as a determinant of the ovarian reserve: differences in ovarian aging between Spanish and Indian women.
Iglesias C Banker M Mahajan N Herrero L García-Velasco JA
Fertil Steril 102(1):244-9, 2014

The impact of using the combined oralcontraceptive pill for cycle scheduling ongene expression related to endometrial receptivity.
Bermejo A Iglesias C Ruiz-Alonso M Blesa D Simón C Pellicer A García-Velasco JA
J Hum Reprod, 29(6):1271-8, 2014

Obstetric outcome after oocyte freezing for fertility preservation in women with cancer.
Martínez M Rabadán S Domingo J Cobo A Pellicer A García-Velasco JA
Reprod Biomed Online, 29:722-728, 2014.

Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression.
Bermejo A Cerrillo M Ruiz-Alonso M Blesa D Simón C Pellicer A García-Velasco JA
Fertil Steril 101(1):138-146, 2014

Increasing the probability of selecting chromosomally normal embryos by time-lapse morphokinetics analysis.
Basile N Nogales MC Bronet F Florensa M Riqueiros M Rodrigo L García-Velasco JA Meseguer M
Fertil Steril, 101:699-704, 2014.

Mild ovarian stimulation using clomiphene citrate and menotropins versus clomiphene citrate and recombinant follicle-stimulating hormone/luteinizing hormone combination in low responder patients
Bermejo A Ruiz F Martínez-Salazar J Mayoral M García-Velasco JA
IVF Lite,1:36-40, 2014.

The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.
Bermejo A Iglesias C Ruiz M Blesa D Simón C Pellicer A García-Velasco JA
Hum Reprod, 29:1271-8, 2014.

Maternal KIR haplotype influence life birth rate after embryo transfer in vitro fertilization (IVF) cycles.
Alecsandru D Garrido N Vicario J Barrio A Aparicio P Requena A García-Velasco JA
Hum Reprod, 29(12):2637-43, 2014.

Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer.
Martínez M Rabadan S Domingo J Cobo A Pellicer A García-Velasco JA
Reprod Biomed Online. 29:722-8, 2014.

Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure.
Alecsandru D Garrido N Vicario J Barrio A Aparicio P, Requena A García-Velasco JA
Hum Reprod. 29:2637-43, 2014.

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sper
Arce JC Andersen AN Fernández-Sánchez M Visnova H Bosch E García-Velasco JA Barri P de Sutter P Klein BM Fauser BC
Fertil Steril. 102:1633-40, 2014.

Response: poor responders and androgen adjuvant treatment: "still haven't found what I'm looking for…".
García-Velasco JA
Reprod Biomed Online. 29:653-4, 2014.

Poor responders and androgen adjuvant treatment: "Still haven't found what I'm looking for...".
García-Velasco JA
Reprod Biomed Online.28:661-2, 2014.

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women.
Iglesias C Banker M Mahajan N Herrero L Meseguer M García-Velasco JA
Fertil Steril. 102:244-9, 2014

Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol.
Fatemi HM Popovic-Todorovic B Humaidan P Kol S Banker M Devroey P García-Velasco JA
Fertil Steril. 101:1008-11, 2014.

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin.
Requena A Cruz M Ruiz F García-Velasco JA
Reprod Biol Endocrinol. 29;12:10, 2014.

Successful twin delivery following transmyometrial embryo transfer in a patient with a false uterine cavity.
Muñoz M Galindo N Pérez-Cano I Cruz M García-Velasco JA
Reprod Biomed Online. 28:137-40, 2014.

Type of culture media does not affect embryo kinetics: a time-lapse analysis of sibling oocytes.
Basile N Morbeck D García-Velasco JA Bronet F Meseguer M
Hum Reprod,28(3):634-41, 2013

In vitro fertilization outcome in women with unoperated bilateral endometriomas
Benaglia L Bermejo A Somigliana E Faulisi S Ragni G Fedele L García-Velasco JA
Fertil Steril, 99:1714-9, 2013

Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial.
Hauzman EE Zapata A Bermejo A Iglesias C Pellicer A García-Velasco JA
Reprod Biol Endocrinol, 11(1):96, 2013

Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression
Bermejo A Cerrillo M Ruiz M Blesa D Simón C Pellicer A García-Velasco JA
Fertil Steril, 101:138-46, 2013.

Natural lh surge vs hCG triggered vs hormone replace treatment (HRT): do pregnancy rates differ?
Cerrillo M Guillen A Zapata A Herrero I Requena A García-Velasco JA
Fertil Steril, 100(3):S95-96, 2013.

5-years experience employing oocyte vitrification to preserve fertility for medical and non-medical indications.
García-Velasco JA Domingo J Cobo A Martínez M Carmona L Pellicer A
Fertil Steril, 99:1994-9, 2013.

Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients?
Cobo A García-Velasco JA Domingo J Pellicer A
Fertil Steril, 99:1485-1495, 2013

Evaluation of the degree of satisfaction in oocyte donors using sustained-release FSH corifollitropin ?.
Requena A Cruz M Collado D Izquierdo A Ballesteros A Muñoz M García-Velasco JA
Reproductive BioMedicine Online, 26(3): 253-259, 2013

Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors.
Bellver J Pellicer A García-Velasco JA Ballesteros A Remohí J Meseguer M
Fertil Steril. 100:1050-8, 2013

GnRH-agonist triggering to avoid ovarian hyperstimulation syndrome: a review of the evidence.
Martínez MC Ruiz FJ García-Velasco JA
Curr Drug Targets. 14:843-9, 2013

Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
García-Velasco JA Domingo J Cobo A Martínez M Carmona L Pellicer A
Fertil Steril. 99:1994-9, 2013.

Oocyte donation and endometriosis: What are the lessons?
Hauzman EE García-Velasco JA Pellicer A
Semin Reprod Med. 31:173-7, 2013.

Sperm DNA fragmentation index does not correlate with the sperm or embryo aneuploidy rate in recurrente miscarriage or implantation failure patients.
Bronet F Martínez E Gaytan M Liñán A Cernuda D Ariza M Nogales M Pacheco A San celestino M García-Velasco JA
Hum Reprod 27: 1922-9, 2012

Manejo expectante de las gestaciones de localización desconocida después de una técnica de reproducción asistida: Manejo clínico, pronóstico y complicaciones asociadas.
Puente J Serna J Martínez M Muñoz J Pacheco A García-Velasco JA
Reproducción, 27(3):126-33 2012.

FSH receptor in vitro modulation by testosterone and hCG in human luteinized granulosa cells.
García-Velasco JA Rodriguez S Agudo Garcillán D Pacheco A Schneider J Pellicer A
Eur J Obst Gynecol Reprod Biol 165: 259-264, 2012.

Ovarian respoonse to controlled ovarian hyperstimulation in cáncer patients is diminished even before oncological treatment.
Domingo J Guillén V Ayllon Y Martínez M Muñoz E Pellicer A García-Velasco JA
Fertil Steril, 97:930-934, 2012

Advances in ovarian hyperstimulation in cancer patients.
Domingo J Guillén V Martínez M Rabadán S Pellicer A García-Velasco JA
US Obstetrics & Gynecology, 7:32-35, 2012

Sperm DNA fragmentation index does not correlate with the sperm or embryo aneuploidy rate in recurrent miscarriage or implantation failure patients.
Bronet F Martínez E Gaytán M Liñán A Cernuda D Ariza M Nogales M Pacheco A San Celestino M García-Velasco JA
Hum Reprod, 27:1922-29, 2012

Pregnancy outcome in women with endometriomas achieving pregnancy through IVF.
Benaglia L Bermejo A Somigliana E Scarduelli C Ragni G Fedele L García-Velasco JA
Hum Reprod, 27:1663-7, 2012.

FSH receptor in vitro modulation by testosterone and hCG in human luteinized granulosa cells
García-Velasco JA Rodríguez S Agudo Garcillán D Pacheco A Schneider J Pellicer A
Eur J Obstet Gynecol Reprod Biol, 165(2):259-64, 2012.

The use of aromatase inhibitors in in vitro fertilization.
García-Velasco JA
Fertil Steril. 98:1356-8, 2012.

Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial.
Kohls G Ruiz F Martínez M Hauzman E de la Fuente G Pellicer A García-Velasco JA
Fertil Steril. 98:858-62, 2012.

Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis.
Prieto L Quesada JF Cambero O Pacheco A Pellicer A Codoceo R García-Velasco JA
Fertil Steril. 98:126-30, 2012.

Patients from across Europe have similar views on patient-centred care: an international multilingual qualitative study in infertility care.
Dancet EA D'Hooghe TM Sermeus W van Empel I Strohmer H Wyns C Santa-Cruz D Nardo LG Kovatchki D Vanlangenakker L García-Velasco JA Mulugeta B Nelen WL Kremer JA
Hum Reprod. 27:1702-11, 2012.

Is there a benefit for surgery in endometrioma-associated infertility?
Ruiz-Flores FJ García-Velasco JA
Curr Opin Obstet Gynecol. 24:136-40, 2012.

Understanding the perceptions of and emotional barriers to infertility treatment: a survey in four European countries.
Domar A Gordon K García-Velasco JA La Marca A Barriere P Beligotti F
Hum Reprod. 27:1073-9, 2012.

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
Domingo J Guillén V Ayllón Y Martínez M Muñoz E Pellicer A García-Velasco JA
Fertil Steril. 97:930-4, 2012.

Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS.
Castillo JC García-Velasco JA Humaidan P
J Assist Reprod Genet. 29:249-53, 2012.

Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos.
García-Velasco JA
Fertil Steril. 97:527-8, 2012.

Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial.
García-Velasco JA Kupesic S Pellicer A Bourgain C Simón C Mrazek M Devroey P Arce JC
Reprod Biomed Online. 24:153-62, 2012.

The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis
Delgado-Rosas F Gómez R Ferrero H Gaytan F García-Velasco JA Simón C Pellicer A
Reproduction.142:745-55, 2011

Aromatase inhibitors in post-menopausal endometriosis.
Polyzos NP Fatemi HM Zavos A Grimbizis G Kyrou D García-Velasco JA Devroey P Tarlatzis B Papanikolaou EG
Reprod Biol Endocrinol, 9:90, 2011.

Multiple pregnancy vanishing twin syndrome
De la Fuente G Puente J García-Velasco JA Pellicer A
Biennial Review o Infertility, Vol 2 103-113, 2011

Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial.
García-Velasco JA Bermejo A Ruiz F Martínez-Salazar J Requena A Pellicer A
Fertil Steril, 96:590-3, 2011.

Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage.
Martínez-Burgos M Herrero L Megías D Salvanes R Montoya MC Cobo A García-Velasco JA
Fertil Steril. 95:374-7, 2011.

Current status of human oocyte and embryo cryopreservation.
Herrero L Martínez M García-Velasco JA
Curr Opin Obstet Gynecol. 23:245-50, 2011.

High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist.
García-Velasco JA Bennink HJ Epifanio R Escudero E Pellicer A Simón C
Reprod Biomed Online. Feb;22 Suppl 1:S52-9, 201

Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome.
Cerrillo M Pacheco A Rodríguez S Gómez R Delgado F Pellicer A García-Velasco JA
Fertil Steril. 95:2517-9, 2011.

Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome.
Herrero L Pareja S Losada C Cobo A Pellicer A García-Velasco JA
Fertil Steril. 95:1137-40,

Estudio comparativo de los ciclos FIV-ICSI sometidos a coasting en el Hospital Universitario materno Infantil de Canarias.
Álvarez M Guillén V Torres A García-Velasco JA Sánchez V

Impacto de un complejo de antioxidantes sobre la fragmentación del ADN espermático en varones infértiles
Balmori C Areces C Pacheco A San Celestino M García-Velasco JA
Rev Int Androl 8: 107-13, 2010

Physiology and pathology of ovarian hyperstimulation syndrome.
Gómez R Soares SR Busso C García-Velasco JA Simón C Pellicer A
Semin Reprod Med. 28:448-57, 2010.

Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new
García-Velasco JA Motta L López A Mayoral M Cerrillo M Pacheco A
Fertil Steril. 94:2820-3, 2010.

Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy.
Novella-Maestre E Carda C Ruiz-Sauri A García-Velasco JA Simón C Pellicer A
Biol Reprod. 83:866-73, 2010.

Human follicular fluid from superovulated women inhibits progesterone receptor-dependent gonadotropin-releasing hormone self-priming in an estrous cycle-dependent manner in the rat.
Gordon A Aguilar R Garrido-Gracia JC Bellido C Millán Y Guil-Luna S García-Velasco JA Muñoz E de las Mulas JM Sánchez-Criado JE
J Endocrinol Invest. 33:564-70, 2010.

The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial.
Busso C Fernández-Sánchez M García-Velasco JA Landeras J Ballesteros A Muñoz E González S Simón C Arce JC Pellicer A
Hum Reprod. 25:995-1004, 2010.

Situación Actual de las técnicas de preservación de la Fertilidad.
Guillén V Domingo S Ayllon Y Domingo J García-Velasco JA
Cuadernos de Medicina Reproductiva, 15:37-47, 2009.

GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use.
Martínez-Salazar J Cerrillo M Quea G Pacheco A García-Velasco JA
Reprod Biomed Online. 19:156-61, 2009.

Comprehensive proteomic analysis of human endometrial fluid aspirate.
Casado-Vela J Rodriguez-Suarez E Iloro I Ametzazurra A García-Velasco JA Matorras R Prieto B González S Nagore D Simón L Elortza F
J Proteome Res. 8:4622-32, 2009.

Circulating estradiol defines the tumor phenotype in menopausal breast cancer patients.
Schneider J Martín-Gutiérrez Tresguerres JA García-Velasco JA
Maturitas. 64:43-5, 2009.

Symposium: Update on prediction and management of OHSS. Prevention of OHSS--dopamine agonists.
Busso CE García-Velasco JA Gomez R Alvarez C Simón C Pellicer A
Reprod Biomed Online. 19:43-51, 2009.

The impact of in-vitro maturation of oocytes on aneuploidy rate.
Requena A Bronet F Guillén A Agudo Garcillán D Bou C García-Velasco JA
Reprod Biomed Online. 18:777-83, 2009.

How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists.
García-Velasco JA
Reprod Biomed Online. 18 Suppl 2:71-5, 2009.

Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
Novella-Maestre E Carda C Noguera I Ruiz-Saurí A García-Velasco JA Simón C Pellicer A
Hum Reprod. 24:1025-35, 2009.

Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
Devroey P Aboulghar M García-Velasco JA Griesinger G Humaidan P Kolibianakis E Ledger W Tomás C Fauser BC
Hum Reprod. 24:764-74, 2009.

Endometrial fluid is a specific and non-invasive biological sample for protein biomarker identification in endometriosis.
Ametzazurra A Matorras R García-Velasco JA Prieto B Simón L Martínez A Nagore D
Hum Reprod. 24:954-65, 2009.

Management of endometriomas in women requiring IVF: to touch or not to touch.
García-Velasco JA Somigliana E.
Hum Reprod. 24:496-501, 2009.

Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction.
Cerrillo M Rodríguez S Mayoral M Pacheco A Martínez-Salazar J García-Velasco JA
Fertil Steril. 91(4 Suppl):1526-8, 2009.

Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial.
García-Velasco JA Quea G Piró M Mayoral M Ruiz M Toribio M Requena A
Fertil Steril. 92:222-5, 2009.

GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.
Giles J Requena A García-Velasco JA Pacheco A Pellicer J Pellicer A
Fertil Steril. 91(4 Suppl):1366-9, 2009.

Clinical Factors affecting endometrial receptiveness in oocyte donation cycles.
Soares SR García-Velasco JA Fernández-Sánchez M Bosch E Remohí J Pellicer A Simón C
Fertil Steril, 89(3):491-501, 2008

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.
Soares SR Gómez R Simón C García-Velasco JA Pellicer A
Hum Reprod Update. 14:321-33, 2008.

Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
Villasante A Pacheco A Pau E Ruiz A Pellicer A García-Velasco JA
Hum Reprod. 23:662-7, 2008.

Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J Cholquevilque JL Cela V Martínez-Salazar J Requena A García-Velasco JA
Fertil Steril. 90:2190-5, 2008.

Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
Oriol B Barrio A Pacheco A Serna J Zuzuarregui JL García-Velasco JA
Fertil Steril, 90(5):1579–82, 2008.

Extended embryo culture to increase implantation rate.
Quea G Romero K García-Velasco JA
Reprod Biomed Online. 14:375-83, 2007.

Aromatase inhibitors in ovarian stimulation.
García-Velasco JA
Reprod Biomed Online. 13:906, 2006.

Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis.
Martínez S Garrido N Coperias JL Pardo F Desco J García-Velasco JA Simón C Pellicer A
Hum Reprod. 22:836-42, 2007.

Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome.
Villasante A Pacheco A Ruiz A Pellicer A García-Velasco JA
J Clin Endocrinol Metab. 92:314-21, 2007.

Crossmodal audio-visual interactions in the primary visual cortex of the visually deprived cat: a physiological and anatomical study.
Sanchez-Vives MV Nowak LG Descalzo VF García-Velasco JA Gallego R Berbel P
Prog Brain Res. 155:287-311, 2006.

Sperm cryopreservation in oncological patients: a 14-year follow-up study.
Meseguer M Molina N García-Velasco JA Remohí J Pellicer A Garrido N
Fertil Steril. 85:640-5, 2006.

Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?
García-Velasco JA Isaza V Quea G Pellicer A
Fertil Steril. 85:547-54, 2006.

Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
Pau E Alonso-Muriel I Gómez R Novella E Ruiz A García-Velasco JA Simón C Pellicer A
Hum Reprod. 21:1453-60, 2006.

Serum interleukin-6 levels are elevated in women with minimal–mild endometriosis.
Martínez S Garrido N Coperias JL Pardo F Desco J García-Velasco JA Simón C Pellicer A
Hum Reprod, 22:836-842, 2006.

Rotura Uterina en Gestación a Término tras metroplastia Histeroscópica.
Sánchez V Guillén V Benito V Torres A Domingo J García-Velasco JA
Progresos de Obstetricia y Ginecología, 48: 311-5, 2005.

¿Son peores los resultados perinatales en las gestaciones únicas conseguidas mediante técnicas de reproducción Asistida?.
Sánchez V Goya MM Torres A Guillén V Delgado C Ramírez O García-Velasco JA
Revista Iberoamericana de Fertilidad, 22: 405-12, 2005.

Endometrioma Ovárico en postmenopausia no relacionado con neoplasia ni hormonoterapia exógena.
Medina N Martín A Guillén V Andujar M García-Velasco JA
Progresos de Obstetricia y ginecología, 48:150-3, 2005.

Medical treatment of endometriosis.
García-Velasco JA Quea G
Minerva Ginecol. 57:249-55, 2005

Impact of endometrioma resection prior to IVF/ICSI cycles.
García-Velasco JA Arici A Pellicer A
Am J Obstet Gynecol. 193:594-5, 2005.

The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.
García-Velasco JA Moreno L Pacheco A Guillén A Duque L Requena A Pellicer A
Fertil Steril. 84:82-7, 2005.

How would revealing the identity of gamete donors affect current practice?
García-Velasco JA Garrido N
Reprod Biomed Online. 10:564-6, 2005.

Effect of repeated assisted reproduction techniques on the ovarian response.
Serna J García-Velasco JA
Curr Opin Obstet Gynecol. 17:233-6, 2005.

139. E-learning in reproductive medicine.
García-Velasco JA Schneider J
Hum Reprod. 20:569-70, 2005.

How would revealing the identity of gamete donors affect current practice?
García-Velasco JA Garrido N
Reprod Biomed Online, 10:564-566, 2005

Eyaculación retrógrada e inseminación artificial, apropósito de un caso.
Padilla M Vega B Nieto MA Guillén V Sánchez V Domingo J García-Velasco JA
Revista Iberoamericana de Fertilidad y Reproducción XXV Congreso Nacional de la SEF, 2004.

Resultados peri natales en los embarazos conseguidos con TRA en el periodo 2000-2003.
García R Plasencia W Benito V Sánchez V Guillén V Domingo J García-Velasco JA
Revista Iberoamericana de Fertilidad y Reproducción XXV Congreso Nacional de la SEF, 2004

Análisis de 2304 ciclos de Inseminación Artificial Intrauterina.
Plasencia W García R Torres A Guillén V Domingo J García-Velasco JA
Revista Iberoamericana de Fertilidad, 21:217-223, 2004.

Resultados de nuestro programa de IAC en función de la causa de esterilidad.
García R Plasencia W Benito V Sánchez V Guillén V Domingo J García-Velasco JA

Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization.
Moreno L Diaz I Pacheco A Zúñiga A Requena A García-Velasco JA
Reprod Biomed Online. 9:500-4, 2004.

Coasting acts through downregulation of VEGF gene expression and protein secretion.
García-Velasco JA Zúñiga A Pacheco A Gómez R Simón C Remohí J Pellicer A
Hum Reprod. 19:1530-8, 2004.

Surgery for the removal of endometriomas before in vitro fertilization does not increase implantation and pregnancy rates.
García-Velasco JA Arici A
Fertil Steril. 81:1206, 2004.

Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study.
García-Velasco JA Mahutte NG Corona J Zúñiga V Gilés J Arici A Pellicer A
Fertil Steril. 81:1194-7, 2004

Clinical experience and perinatal outcome of blastocyst transfer after coculture of human embryos with human endometrial epithelial cells: a 5-year follow-up study.
Mercader A García-Velasco JA Escudero E Remohí J Pellicer A Simón C
Fertil Steril. 80:1162-8, 2003.

Apoptosis and the pathogenesis of endometriosis.
García-Velasco JA Arici A
Semin Reprod Med. 21:165-72, 2003.

New concepts in the understanding of the ovarian hyperstimulation syndrome.
García-Velasco JA Pellicer A
Curr Opin Obstet Gynecol. 15:251-6, 2003.

Factors that determine discordant outcome from shared oocytes.
García-Velasco JA Isaza V Caligara C Pellicer A Remohí J Simón C
Fertil Steril. 80:54-60, 2003.

Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny.
Lavado-Autric R Ausó E García-Velasco JA Arufe Mdel C Escobar del Rey F Berbel P Berbel P Morreale de Escobar G
J Clin Invest. 111:1073-82, 2003.

Recombinant vs. urinary follicle-stimulating hormone in couples undergoing intrauterine insemination. A randomized study.
Isaza V Requena A García-Velasco JA Remohí J Pellicer A Simón C
J Reprod Med. 48:112-8, 2003.

Resultados de 451 ciclos de inseminación artificial realizados en 2001.
Sánchez V Domingo J Prieto M Martel C Guillén V García-Velasco JA
Revista Iberoamericana de Fertilidad y Reproducción, Número Especial XXVI: 336, 2002.

Seguimiento de 237 pacientes incluidas en nuestro programa de inseminación artificial.
Martel C Torres A Sánchez V Prieto M Guillén V Domingo J García-Velasco JA
Revisa Iberoamericana de Fertilidad y Reproducción. Número Especial XXVI: 336, 2002.

Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis.
García-Velasco JA Mulayim N Kayisli UA Kayisli UA
Fertil Steril. 78:855-9, 2002

Transabdominal ultrasound-guided embryo transfer does not increase pregnancy rates in oocyte recipients.
García-Velasco JA Isaza V Martínez-Salazar J Landazábal A Requena A Remohí J Simón C
Fertil Steril. 78:855-9, 2002.

Regulation of fas ligand expression by IL-8 in human endometrium.
Selam B Kayisli UA García-Velasco JA Akbas GE Arici A
Fertil Steril. 78:534-9, 2002.

Oocyte and embryo quality after coasting: the experience from oocyte donation.
Isaza V García-Velasco JA Aragonés M Remohí J Simón C Pellicer A
J Clin Endocrinol Metab. 87:3921-7, 2002.

Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells.
Seli E Pehlivan T Selam B García-Velasco JA Arici A
Hum Reprod. 17:1777-82, 2002.

The "vanishing embryo" phenomenon in an oocyte donation programme.
Rodríguez-González M Serra V García-Velasco JA Pellicer A Remohí J
Fertil Steril. 77:542-7, 2002.

The endometrium versus embryonic quality in endometriosis-related infertility.
Garrido N Navarro J García-Velasco JA Remohí J Pellicer A Remohí J
Hum Reprod. 17:798-802, 2002.

Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells.
Selam B Kayisli UA García-Velasco JA Arici A
Biol Reprod. 66:1-5, 2002.

Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).
García-Velasco JA Isaza V Vidal C Landazabal A Remohí J Simón C Pellicer A
Hum Reprod, 16(12):2533-9, 2001.

Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix)
García-Velasco JA Isaza V Vidal C Landazábal A Remohí J Simón C Pellicer A
Hum Reprod. 16:2533-9, 2001.

Role of thyroid hormones in the maturation and organisation of rat barrel cortex.
Berbel P Ausó E García-Velasco JA Molina M Camacho M
Neuroscience. 107:383-94, 2001.

Endometrial quality in infertile women with endometriosis.
Pellicer A Navarro J Bosch E Garrido N García-Velasco JA Remohí J Simón C
Ann N Y Acad Sci. 943:122-30, 2001.

Blastocyst transfer: does it really affect the outcome?
García-Velasco JA Simón C
Curr Opin Obstet Gynecol. 13:299-304, 2001.

Endometrial receptivity in terms of pinopode expression is not impaired in women with endometriosis in artificially prepared cycles.
García-Velasco JA Nikas G Remohí J Pellicer A Simón C
Fertil Steril. 75:1231-3, 2001.

Clinical experience employing co-culture of human embryos with autologous human endometrial epithelial cells.
Rubio C Simón C Mercader A García-Velasco JA Remohí J Pellicer A
Hum Reprod. 15 Suppl 6:31-8, 2000.

High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial.
García-Velasco JA Isaza V Requena A Martínez-Salazar FJ Landazábal A Remohí J Pellicer A Simón C
Hum Reprod 15:2292-6, 2000

Empty follicle syndrome: evidence for recurrence.
Zreik TG García-Velasco JA Vergara TM Arici A Olive D Jones EE
Hum Reprod. 15:999-1002, 2000.

Endogenous LH surge detection versus administration of HCG to correctly time intrauterine insemination: which provides a better pregnancy rate?
García-Velasco JA Arici A Zreik TG
Hum Reprod. 15:975-6, 2000.

Regulation of monocyte chemotactic protein-1 expression in human endometrial cells by integrin-dependent cell adhesion.
García-Velasco JA Seli E Arici A
Biol Reprod 61:548-52, 1999.

Is the endometrium or oocyte/embryo affected in endometriosis?
García-Velasco JA Arici A
Hum Reprod. 14 Suppl 2:77-89, 1999.

Unicornuate uterus with a rudimentary horn and ovarian dysgerminoma. A case report.
Zreik TG Pustilnik TB García-Velasco JA Rutherford T Troiano RN Olive DL
J Reprod Med. 44:1025-8, 1999.

Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion.
García-Velasco JA Arici A
Mol Hum Reprod. 5:1135-40, 1999.

Coculture of human embryos with autologous human endometrial epithelial cells in patients with implantation failure.
Simón C Mercader A García-Velasco JA Nikas G Moreno C Remohí J Pellicer A
J Clin Endocrinol Metab. 84:2638-46, 1999.

Interleukin-8 stimulates the adhesion of endometrial stromal cells to fibronectin.
García-Velasco JA Arici A
Fertil Steril. 72:336-40, 1999.

Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by integrin-dependent cell adhesion.
García-Velasco JA Seli E Arici A
Biol Reprod. 61 :548-52, 1999.

Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis.
García-Velasco JA Arici A Zreik T Naftolin F Mor G
Mol Hum Reprod. 5:642-50, 1999.

Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimula
Zreik TG García-Velasco JA Habboosh M Olive DL Arici A
Fertil Steril. 71:1070-4, 1999.

Chemokines and human reproduction.
García-Velasco JA Arici A
Fertil Steril. 71:983-93. 1999.

A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulatio
Out HJ Lindenberg S Mikkelsen A Eldar-Geva T Healy DL Leader A Rodriguez-Escudero F García-Velasco JA Pellicer A
Hum Reprod. 14:622-7. 1999.

Potential implications of chemokines in reproductive function: an attractive idea.
Simón C Caballero-Campo P García-Velasco JA Pellicer A
J Reprod Immunol. 38: 169-93. 1998.

Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen.
Simón C García-Velasco JA Valbuena D Peinado J Moreno C Remohí J Pellicer A
Fertil Steril. 70:234-9, 1998.

Increasing the length of the middle crura for better tip projection in primary rhinoplasty.
García-Velasco JA Vidal JT García-Casas S
Aesthetic Plast Surg. 22:253-8, 1998.

A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor
García-Velasco JA González A
Int J Gynaecol Obstet. 61:239-44, 1998

Rupture of an ovarian endometrioma during the first trimester of pregnancy.
García-Velasco JA Alvarez M Palumbo A González A Ordás J
Eur J Obstet Gynecol Reprod Biol. 76:41-3, 1998.

Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation.
Remohí J Ardiles G García-Velasco JA Gaitán P Simón C Pellicer A
Hum Reprod. 12 :2271-6, 1997.

Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women.
Cano F García-Velasco JA Millet A Remohí J Simón C Pellicer A
J Assist Reprod Genet. 14:254-61, 1997.

Repercusión of the hormonal substitute therapy in the antitrombin III.
Seara S Guillén V Santiago L Blanco C Rodríguez R Morin J García-Velasco JA
Endocrinology 1996. 10 (suppl 4): 273

Repercusión Of the hormonal substitute therapy in the blood pressure.
Seara S Guillén V Blanco C Santiago L Cabrera F Morin J García-Velasco JA
Gynecol Endocrinol, 10 (suppl 4): 273, 1996.

Repercusión of estrogenotherapy whit and whithout oppsosition of progesteronq therapy in the blood pressure.
Seara S Guillén V Blanco C Santiago L Cabrera F Morin J García-Velasco JA
Endocrinology, 10 (suppl 4): 274, 1996.

Maternal serum creatine kinase: a possible predictor of tubal pregnancy?
García-Velasco JA Requena A Santisteban J
Am J Obstet Gynecol. 175:238-40, 1996.

Papel del antígeno de células escamosas (SCC-Ag) en el diagnóstico y tratamiento del cáncer de cervix uterino.
Hernández S López B Guillen V Valle L Lara P Apolinario R García-Velasco JA Falcón O
Progresos de obstetricia y ginecología, 38:381-385, 1995.

Miastenia Gravis y embarazo (a propósito de 3 casos).
Cuadrado J Cerezuela JF Gálvez J Guillén V Ocón L García-Velasco JA
Progresos de Obstetricia y Ginecología, 36:413-416, 1993.

Juan García Velasco, M.D., Ph.D.

Biography

Education and Training

Honors and recognition

Research activity:

Publications

Videos